Risk of blood clot eight times higher for Covid-19 than for AstraZeneca vaccine

Compared to the AZ-Oxford vaccine, the risk of a CVT from COVID-19 is about 8 times greater.

The risk of developing a blood clot after contracting the coronavirus is eight times higher than after receiving the Oxford-AstraZeneca vaccine, according to a study by Oxford University.

In the study of over 500,000 COVID-19 patients, cerebral venous thrombosis (CVT) occurred in 39 in a million COVID-19 patients, compared with about five in a million people given the Oxford-AstraZeneca jab.